Key facts
- Celltrion (KRX: 068270) is a other based in Incheon, South Korea.
About Celltrion (KRX: 068270)
Celltrion is a corporation based in Incheon, South Korea. Established in 2002, the company is engaged in the research, development, and manufacture of therapeutic proteins. The company manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others. The assets of the company are managed by the board of directors.
Free account
See the whole book
- ·Watchlist + alerts for Celltrion (KRX: 068270)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Celltrion (KRX: 068270) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.